...
首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
【24h】

Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia

机译:埃塞俄比亚西南吉马大学专科医院的人类免疫缺陷病毒感染者的糖尿病及危险因素

获取原文
           

摘要

Background: Globally, diabetes is rising dramatically causing high health burden in low- and middle-income countries. It is estimated that about 382 million people had diabetes in 2013. In 2013, diabetes caused 5.1 million deaths globally. Almost 80% of diabetes deaths occur in low- and middle-income countries. Purpose: To assess the magnitude of diabetes mellitus (DM) and associated risk factors in human immunodeficiency virus (HIV)-infected individuals. Methods: An institution-based cross-sectional study was conducted from April to May 2014 at Jimma University Specialized Hospital. Convenient sampling technique was implemented. Sociodemographic and anthropometric data were collected by senior clinical nurses. Venous blood was collected from each study participant. Serum glucose and lipid profile of the study participants was measured using HumaStar 80 spectrophotometer. Data were analyzed using SPSS version 20. Bivariate and multivariate logistic regressions were utilized. Results: A total of 393 HIV-infected individuals of age ranging from 21 years to 75 years had enrolled in this study. The overall prevalence of DM in this study was 6.4% (n=25). Two hundred and ninety-one (74%) and 77 (19.6%) of the study participants had normal (70–110 mg/dL) and impaired (111–125 mg/dL) fasting blood glucose values, respectively. After adjusting for the other variables, age (adjusted odds ratio [AOR] =4.812, 95% confidence interval [CI]: 1.668–13.881, P=0.004), duration of highly active antiretroviral therapy (HAART) (AOR =26.928, 95% CI: 3.722–194.822, P=0.001), hypertension (AOR =4.779, 95% CI: 1.646–13.874, P=0.004), and low-density lipoprotein cholesterol (AOR =5.669, 95% CI: 1.849–17.382, P=0.004) were significantly associated with DM. Conclusion: HAART may have an impact on the cause of diabetes. Hence, HIV-infected individuals should be screened for diabetes, both before and after initiation of HAART.
机译:背景:在全球范围内,糖尿病在急剧上升,在中低收入国家中造成很高的健康负担。据估计,2013年约有3.82亿人患有糖尿病。2013年,糖尿病在全球造成510万人死亡。几乎80%的糖尿病死亡发生在低收入和中等收入国家。目的:评估感染人类免疫缺陷病毒(HIV)的个体的糖尿病(DM)的程度和相关的危险因素。方法:2014年4月至2014年5月在吉马大学专业医院进行了基于机构的横断面研究。实施了方便的采样技术。社会人口统计学和人体测量学数据由资深临床护士收集。从每个研究参与者收集静脉血。使用HumaStar 80分光光度计测量研究参与者的血清葡萄糖和脂质谱。使用SPSS版本20分析数据。使用了双变量和多元logistic回归。结果:共有393名年龄在21岁至75岁之间的HIV感染者参加了这项研究。这项研究中DM的总体患病率为6.4%(n = 25)。空腹血糖值分别为正常(70–110 mg / dL)和受损(111–125 mg / dL)的研究参与者中的211(74%)和77(19.6%)。调整其他变量后,年龄(校正比值比[AOR] = 4.812,95%置信区间[CI]:1.668–13.881,P = 0.004),高效抗逆转录病毒疗法(HAART)的持续时间(AOR = 26.928,95 %CI:3.722–194.822,P = 0.001),高血压(AOR = 4.779,95%CI:1.646–13.874,P = 0.004)和低密度脂蛋白胆固醇(AOR = 5.669,95%CI:1.849–17.382, P = 0.004)与DM显着相关。结论:HAART可能对糖尿病的病因有影响。因此,在开始进行HAART之前和之后,都应该对HIV感染者进行糖尿病筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号